Dermatology
Zeile 65: | Zeile 65: | ||
{{tp|p=32455505|t=2020. Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children.|pdf=|usr=007}} | {{tp|p=32455505|t=2020. Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children.|pdf=|usr=007}} | ||
{{tp|p=32344307|t=2020. COVID-19 type III hypersensitivity reaction |pdf=|usr=}} | {{tp|p=32344307|t=2020. COVID-19 type III hypersensitivity reaction |pdf=|usr=}} | ||
+ | {{tp|p=32455499|t=2020. Late onset of acral necrosis after SARS-CoV-2 infection resolution.|pdf=|usr=007}} | ||
+ | {{tp|p=32453902|t=2020. Chilblains-like lesions and COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32445583|t=2020. Erythema multiforme-like lesions in children and COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32484624|t=2020. COVID-19 Pandemic: Are There Unique Cutaneous Manifestations in Patients Infected With SARS-CoV-2?|pdf=|usr=007}} | ||
+ | {{tp|p=32426864|t=2020. A clinicopathological study of 8 patients with COVID-19 pneumonia and a late-onset exanthema.|pdf=|usr=007}} | ||
+ | {{tp|p=32421877|t=2020. A late-onset widespread skin rash in a previous COVID-19-infected patient: viral or multidrug effect?|pdf=|usr=007}} | ||
+ | {{tp|p=32421876|t=2020. Chilblain acral lesions in the COVID-19 era. Are they marker of infection in asymptomatic patients?|pdf=|usr=007}} | ||
+ | {{tp|p=32453865|t=2020. Cutaneous small-vessel vasculitis associated with novel 2019 coronavirus SARS-CoV-2 infection (COVID-19).|pdf=|usr=007}} | ||
+ | {{tp|p=32452545|t=2020. Are chilblain-like acral skin lesions really indicative of COVID-19? A prospective study and literature review.|pdf=|usr=007}} | ||
+ | {{tp|p=32452542|t=2020. COVID-19 Presenting with Atypical Sweet's Syndrome.|pdf=|usr=007}} | ||
+ | {{tp|p=32441876|t=2020. Cutaneous small vessel vasculitis secondary to COVID-19 infection: A case report.|pdf=|usr=007}} | ||
+ | {{tp|p=32441830|t=2020. Diversity of clinical appearance of cutaneous manifestations in the course of COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32434277|t=2020. Acral purpuric lesions (erythema multiforme type) associated with thrombotic vasculopathy in a child during the COVID-19 pandemic.|pdf=|usr=007}} | ||
+ | {{tp|p=32428303|t=2020. COVID-19 and dermatology: a comprehensive guide for dermatologists.|pdf=|usr=007}} | ||
+ | {{tp|p=32428291|t=2020. Fever with Rash in COVID-19: Viral Exanthema or Secondary Lesions?|pdf=|usr=007}} | ||
+ | {{tp|p=32447761|t=2020. Dermatological findings in COVID-19 patients: Mexican experience.|pdf=|usr=007}} | ||
+ | {{tp|p=32409442|t=2020. Skin manifestations of COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32474947|t=2020. A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32510648|t=2020. Urticarial vasculitis in COVID-19 infection: a vasculopathy-related symptom?|pdf=|usr=007}} | ||
+ | {{tp|p=32500642|t=2020. Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not "varicella-like".|pdf=|usr=007}} | ||
+ | {{tp|p=32495400|t=2020. Exanthema and eosinophilia in Covid-19 patients: has viral infection a role in drug induced exanthemas?|pdf=|usr=007}} | ||
+ | {{tp|p=32495368|t=2020. Clinical and histological characterization of late appearance maculopapular eruptions in association with the coronavirus disease 2019. A case series of seven patients.|pdf=|usr=007}} | ||
+ | {{tp|p=32491234|t=2020. Retiform purpura as a dermatological sign of covid-19 coagulopathy.|pdf=|usr=007}} | ||
+ | {{tp|p=32491223|t=2020. COVID-19: how it can look on the skin. Clinical and pathological features in twenty COVID-19 patients observed in Bologna, northeastern Italy.|pdf=|usr=007}} | ||
+ | {{tp|p=32488946|t=2020. No antibody response in acral cutaneous manifestations associated with COVID-19 ?|pdf=|usr=007}} | ||
+ | {{tp|p=32488910|t=2020. Acro-ischemia and COVID-19 infection: clinical and histopathological features.|pdf=|usr=007}} | ||
+ | {{tp|p=32497704|t=2020. Comment on: "Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak".|pdf=|usr=007}} | ||
+ | {{tp|p=32496583|t=2020. Chilblain-like lesions during the COVID-19 pandemic: should we really worry?|pdf=|usr=007}} | ||
+ | {{tp|p=32496578|t=2020. Chilblains-like dermatologic manifestation of COVID-19 diagnosed by serology via multidisciplinary virtual care.|pdf=|usr=007}} | ||
+ | {{tp|p=32495913|t=2020. Severe acute dried gangrene in COVID-19 infection: a case report.|pdf=|usr=007}} | ||
+ | {{tp|p=32475035|t=2020. Contributions of dermatologists to COVID-19 research: a brief systematic review.|pdf=|usr=007}} | ||
+ | {{tp|p=32458546|t=2020. Cutaneous manifestations of COVID-19: A review of the published literature.|pdf=|usr=007}} | ||
+ | {{tp|p=32447798|t=2020. Are erythema multiforme and urticaria related to a better outcome of COVID-19?|pdf=|usr=007}} | ||
+ | {{tp|p=32438476|t=2020. Reply to "Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital": Pseudoherpetic Grover disease seems to appear in patients with COVID-19 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32421857|t=2020. Novel outbreak of acral lesions in times of COVID-19: A description of 74 cases from a tertiary university hospital in Spain.|pdf=|usr=007}} | ||
+ | {{tp|p=32436736|t=2020. Visual Dermatology: Acral Erythemato-purpuric Lesions During COVID-19 Pandemic.|pdf=|usr=007}} | ||
+ | {{tp|p=32391713|t=2020. Cutaneous Manifestations of Coronavirus Disease 2019 (COVID-19) Infection-What Do We Know So Far?|pdf=|usr=007}} | ||
+ | {{tp|p=32441750|t=2020. Angioedema in COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32500580|t=2020. Schamberg-like purpuric eruptions and tonsillitis in mild COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32506813|t=2020. A fatal case of COVID-19 infection presenting with an erythema multiforme-like eruption and fever.|pdf=|usr=007}} | ||
+ | {{tp|p=32500647|t=2020. Dermatological Manifestation of Pediatrics Multisystem Inflammatory Syndrome Associated with COVID-19 in a 3-Year-Old Girl.|pdf=|usr=007}} | ||
+ | {{tp|p=32460349|t=2020. Further evidence that chilblains are a cutaneous manifestation of COVID-19 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32479680|t=2020. Cutaneous manifestations in patients with COVID-19: A preliminary review of an emerging issue.|pdf=|usr=007}} | ||
+ | {{tp|p=32424886|t=2020. The management of the outbreak of acral skin manifestations in asymptomatic children during COVID-19 era.|pdf=|usr=007}} | ||
+ | {{tp|p=32418320|t=2020. Urticaria in a patient with COVID-19: Therapeutic and diagnostic difficulties.|pdf=|usr=007}} |
Version vom 28. Juni 2020, 20:26 Uhr
coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.
32294259 2020. A distinctive skin rash associated with Coronavirus Disease 2019 ?
32294270 2020. Viral exanthem in COVID-19, a clinical enigma with biological significance
32330336 2020. SARS-CoV-2 infection presenting as a febrile rash
32283235 ä. Various forms of skin rash in COVID-19 : a reply
32352486 2020. Digitate Papulosquamous Eruption Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
32301221 2020. A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain - A potential clue to the role of androgens in COVID-19 severity
livedo reticularis
32283229 ä. A dermatologic manifestation of COVID-19: Transient livedo reticularis
petechial
32352487 2020. Petechial Skin Rash Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
32213305 2020. COVID-19 can present with a rash and be mistaken for dengue
32283233 ä. Reply to ?COVID-19 can present with a rash and be mistaken for Dengue?: Petechial rash in a patient with COVID-19 infection
varicella-like
32305439 ä. Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients
32380215 ä. Reply to Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients?: discussing specificity
32315079 2020. Varicella-like exanthem associated with COVID-19 in an 8-year-old girl: A diagnostic clue?
morbilliform
32313826 ä. Morbilliform exanthem associated with COVID-19
urticaria-like
32352022 2020. Urticarial exanthem as early diagnostic clue for COVID-19 infection
32329915 2020. Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection
32294273 2020. Urticarial eruption in COVID-19 infection
vesiculo-bullous
32369674 2020. Oral vesiculobullous lesions associated with SARS-CoV-2 infection
pemphigoid (as co-morbidity)
32363963 2020. Mucous membrane pemphigoid and COVID-19 treated with high-dose intravenous immunoglobulins: a case report
32359182 2020. Occurrence of SARS-CoV-2 during mycophenolate mofetil treatment for pemphigus
pernio
32418860 ä. Lesiones cuteneas tipo perniosis durante la epidemia COVID-19
32402775 ä. Perniosis del confinamiento, una vieja conocida en el contexto del COVID-19
Pityriasis rosea
32359180 2020. Pityriasis rosea as a cutaneous manifestation of COVID-19 infection
case reports
32346588 ä. Dermatologic findings in two patients with COVID-19
32353170 2020. Cutaneous lesions in a patient with COVID-19: are they related?
32282312 2020. A Case of COVID-19 Pneumonia in a Young Male with Full Body Rash as a Presenting Symptom
32358979 2020. Diffuse cutaneous manifestation in a new mother with COVID-19 (SARS-Cov-2)
32366113 2020. Foot Manifestations in a COVID-19 Positive Patient: A Case Study
32330339 2020. Cutaneous manifestation of COVID-19 in images: a case report
32330322 2020. Did Whatsapp reveal a new cutaneous COVID-19 manifestation?
32294264 2020. Cutaneous manifestations in COVID-19: a new contribution
32402385 ä. Manifestaciones cutaneas ... un caso
32420946 2020. COVID-19 and food allergy in children.
32455505 2020. Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children.
32344307 2020. COVID-19 type III hypersensitivity reaction
32455499 2020. Late onset of acral necrosis after SARS-CoV-2 infection resolution.
32453902 2020. Chilblains-like lesions and COVID-19.
32445583 2020. Erythema multiforme-like lesions in children and COVID-19.
32484624 2020. COVID-19 Pandemic: Are There Unique Cutaneous Manifestations in Patients Infected With SARS-CoV-2?
32426864 2020. A clinicopathological study of 8 patients with COVID-19 pneumonia and a late-onset exanthema.
32421877 2020. A late-onset widespread skin rash in a previous COVID-19-infected patient: viral or multidrug effect?
32421876 2020. Chilblain acral lesions in the COVID-19 era. Are they marker of infection in asymptomatic patients?
32453865 2020. Cutaneous small-vessel vasculitis associated with novel 2019 coronavirus SARS-CoV-2 infection (COVID-19).
32452545 2020. Are chilblain-like acral skin lesions really indicative of COVID-19? A prospective study and literature review.
32452542 2020. COVID-19 Presenting with Atypical Sweet's Syndrome.
32441876 2020. Cutaneous small vessel vasculitis secondary to COVID-19 infection: A case report.
32441830 2020. Diversity of clinical appearance of cutaneous manifestations in the course of COVID-19.
32434277 2020. Acral purpuric lesions (erythema multiforme type) associated with thrombotic vasculopathy in a child during the COVID-19 pandemic.
32428303 2020. COVID-19 and dermatology: a comprehensive guide for dermatologists.
32428291 2020. Fever with Rash in COVID-19: Viral Exanthema or Secondary Lesions?
32447761 2020. Dermatological findings in COVID-19 patients: Mexican experience.
32409442 2020. Skin manifestations of COVID-19.
32474947 2020. A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection.
32510648 2020. Urticarial vasculitis in COVID-19 infection: a vasculopathy-related symptom?
32500642 2020. Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not "varicella-like".
32495400 2020. Exanthema and eosinophilia in Covid-19 patients: has viral infection a role in drug induced exanthemas?
32495368 2020. Clinical and histological characterization of late appearance maculopapular eruptions in association with the coronavirus disease 2019. A case series of seven patients.
32491234 2020. Retiform purpura as a dermatological sign of covid-19 coagulopathy.
32491223 2020. COVID-19: how it can look on the skin. Clinical and pathological features in twenty COVID-19 patients observed in Bologna, northeastern Italy.
32488946 2020. No antibody response in acral cutaneous manifestations associated with COVID-19 ?
32488910 2020. Acro-ischemia and COVID-19 infection: clinical and histopathological features.
32497704 2020. Comment on: "Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak".
32496583 2020. Chilblain-like lesions during the COVID-19 pandemic: should we really worry?
32496578 2020. Chilblains-like dermatologic manifestation of COVID-19 diagnosed by serology via multidisciplinary virtual care.
32495913 2020. Severe acute dried gangrene in COVID-19 infection: a case report.
32475035 2020. Contributions of dermatologists to COVID-19 research: a brief systematic review.
32458546 2020. Cutaneous manifestations of COVID-19: A review of the published literature.
32447798 2020. Are erythema multiforme and urticaria related to a better outcome of COVID-19?
32438476 2020. Reply to "Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital": Pseudoherpetic Grover disease seems to appear in patients with COVID-19 infection.
32421857 2020. Novel outbreak of acral lesions in times of COVID-19: A description of 74 cases from a tertiary university hospital in Spain.
32436736 2020. Visual Dermatology: Acral Erythemato-purpuric Lesions During COVID-19 Pandemic.
32391713 2020. Cutaneous Manifestations of Coronavirus Disease 2019 (COVID-19) Infection-What Do We Know So Far?
32441750 2020. Angioedema in COVID-19.
32500580 2020. Schamberg-like purpuric eruptions and tonsillitis in mild COVID-19.
32506813 2020. A fatal case of COVID-19 infection presenting with an erythema multiforme-like eruption and fever.
32500647 2020. Dermatological Manifestation of Pediatrics Multisystem Inflammatory Syndrome Associated with COVID-19 in a 3-Year-Old Girl.
32460349 2020. Further evidence that chilblains are a cutaneous manifestation of COVID-19 infection.
32479680 2020. Cutaneous manifestations in patients with COVID-19: A preliminary review of an emerging issue.
32424886 2020. The management of the outbreak of acral skin manifestations in asymptomatic children during COVID-19 era.
32418320 2020. Urticaria in a patient with COVID-19: Therapeutic and diagnostic difficulties.